Showing results (151-160 of 358) with videos related to
Sort By:
Pageof 36
The Journal of Infectious Diseases|March 1, 1995
Effect of secretor status on vaginal and rectal colonization with fimbriated Escherichia coli in women with and without recurrent urinary tract infectionA Stapleton, T M Hooton, C Fennell, et al.JAMA|January 2, 1991
Escherichia coli bacteriuria and contraceptive methodT M Hooton, S Hillier, C Johnson, et al.JAMA|December 20, 1985
Laboratory diagnosis of urinary tract infection in ambulatory womenR H Latham, E S Wong, A Larson, et al.The Journal of Infectious Diseases|August 1, 1995
Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young womenT A Russo, A Stapleton, S Wenderoth, et al.Sexually Transmitted Diseases|March 26, 2002
Epidemiology of anorectal chlamydial and gonococcal infections among men having sex with men in Seattle: utilizing serovar and auxotype strain typingWilliam M Geisler, William L H Whittington, Robert J Suchland, et al.Nederlands Tijdschrift Voor Geneeskunde|September 30, 1989
[Serotype distribution of urogenitally located Chlamydia trachomatis in Rotterdam]J H Wagenvoort, R J Suchland, T van Rijsoort-Vos, et al.The American Journal of Medicine|June 23, 1999
The effectiveness of a clinical practice guideline for the management of presumed uncomplicated urinary tract infection in womenS Saint, D Scholes, S D Fihn, et al.Sexually Transmitted Diseases|February 5, 2003
The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infectionWilliam M Geisler, Robert J Suchland, William L H Whittington, et al.Antimicrobial Agents and Chemotherapy|February 25, 2005
Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazilRobert J Suchland, Agnès Bourillon, Erick Denamur, et al.Annals of Internal Medicine|March 1, 1988
Trimethoprim-sulfamethoxazole for acute dysuria in women: a single-dose or 10-day course. A double-blind, randomized trialS D Fihn, C Johnson, P L Roberts, et al.Pageof 36